Galecto Inc
NASDAQ:GLTO
Galecto Inc
Total Current Liabilities
Galecto Inc
Total Current Liabilities Peer Comparison
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Total Current Liabilities
$5.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Total Current Liabilities
kr2.8B
|
CAGR 3-Years
29%
|
CAGR 5-Years
45%
|
CAGR 10-Years
12%
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Total Current Liabilities
kr275.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
22%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Total Current Liabilities
€799m
|
CAGR 3-Years
122%
|
CAGR 5-Years
90%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Total Current Liabilities
kr2.9B
|
CAGR 3-Years
27%
|
CAGR 5-Years
68%
|
CAGR 10-Years
27%
|
Bioporto A/S
CSE:BIOPOR
|
Total Current Liabilities
kr25.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
See Also
What is Galecto Inc's Total Current Liabilities?
Total Current Liabilities
5.8m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Total Current Liabilities amounts to 5.8m USD.
What is Galecto Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
6%
Over the last year, the Total Current Liabilities growth was -47%. The average annual Total Current Liabilities growth rates for Galecto Inc have been 1% over the past three years , 6% over the past five years .